Fatigue Syndrome, Chronic Clinical Trial
Official title:
Study to Determine the Effectiveness of Therapy Methods (Acceptance Commitment Therapy, Micro Breaks) in Patients With Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a distinct disease entity with an estimated prevalence of 0.3-0.7% and more common in women (3:1 ratio). It can be diagnosed according to the Institute of Medicine (IOM) 2015 consensus definition using 3 major criteria and one of 2 minor criteria. Diagnosis requires that the patient have the following three symptoms: 1. A substantial reduction or impairment in the ability to engage in pre-illness levels of occupational, educational, social, or personal activities that persists for more than 6 months and is accompanied by fatigue, which is often profound, is of new or definite onset (not lifelong), is not the result of ongoing excessive exertion, and is not substantially alleviated by rest, 2. Post-exertional malaise,* and 3. Unrefreshing sleep* At least one of the two following manifestations is also required: 1. Cognitive impairment* or 2. Orthostatic intolerance Note* Frequency and severity of symptoms should be assessed. The diagnosis of ME/CFS should be questioned if patients do not have these symptoms at least half of the time with moderate, substantial, or severe intensity. Currently, individually tailored therapy with emphasis on cognitive behavioral therapy and graduated activity therapy is considered the therapy of first choice, although their effectiveness has been critically questioned in recent years. There are often frustrating treatment courses, a larger proportion of partial remissions, a significantly smaller proportion of full remissions and return to work. The study aims to evaluate patients of the outpatient service for chronic fatigue at the Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, Switzerland, in the context of a group therapy for the treatment of CFS/ME in respect to the response to different, non-drug based therapeutic procedures and to gain knowledge about the effects of the therapy. The study is a clinical comparative study of therapeutic procedures/interventions without the use of drugs or a medical product. The interventions are Acceptance Commitment Therapy (ACT) and Micro Breaks in Everyday Life (MBEL) adapted to CFS/ME. The collection of biological samples (saliva, blood) and health-related personal data (actigraphy, psychometric data from questionnaires) is associated with minimal risks and burdens.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05899595 -
Effects of a Personalized Physical Training to Reduce Fatigue
|
N/A | |
Not yet recruiting |
NCT01154647 -
Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes
|
N/A | |
Completed |
NCT00375973 -
Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT02499302 -
Mental Training for CFS Following EBV Infection in Adolescents
|
N/A | |
Completed |
NCT02156128 -
Subjective Memory Complaints, Objective Memory Performance and Cognitive Training
|
N/A | |
Not yet recruiting |
NCT06386133 -
Chronic Fatigue in Multiple Sclerosis: MS Copilot Boost Solution Compared to Standard Care
|
N/A | |
Not yet recruiting |
NCT05116657 -
Obstructive Sleep Apnoea Post Covid 19: Role of the Upper Airway Microbiome
|
||
Completed |
NCT00788918 -
Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
|
N/A | |
Completed |
NCT04435002 -
The Effect of Acupressure on Fatigue in Individuals With Chronic Fatigue Syndrome
|
N/A | |
Recruiting |
NCT05778006 -
Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (ME/CFS) Registry and Biobank, COVID-19, SARS-CoV-2
|
||
Recruiting |
NCT06253026 -
Fatigue in Air Search and Rescue Missions
|
||
Completed |
NCT00001415 -
Glucocorticoid Effects on Cellular Cytokine Release
|
N/A | |
Completed |
NCT04797871 -
Resistance Training and Clinical Status in Patients With Post Discharge Symptoms After Covid-19
|
N/A | |
Recruiting |
NCT04049331 -
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
|
Phase 2 | |
Completed |
NCT02335437 -
Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents
|
N/A | |
Recruiting |
NCT05728918 -
Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People
|
N/A | |
Completed |
NCT04833673 -
The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized Trial
|
N/A | |
Recruiting |
NCT04947488 -
Evaluation of the Effects of Treatment With Bioarginin C in Adult Subjects Belonging to the Post-Covid Day Hospital
|
N/A | |
Recruiting |
NCT05840237 -
REGAIN: RCT of Oxaloacetate for Fatigue in Long COVID
|
N/A | |
Active, not recruiting |
NCT04104750 -
The Assessment of Fatigue and Quality of Life in Patients With Bone Tumor,
|